Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-11 21:19:28 UTC |
---|
Update Date | 2022-03-07 02:54:50 UTC |
---|
HMDB ID | HMDB0036262 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Annoglabasin E |
---|
Description | Annoglabasin E belongs to the class of organic compounds known as kaurane diterpenoids. These are diterpene alkaloids with a structure that is based on the kaurane skeleton. Kaurane is a tetracyclic compound that arises by cyclisation of a pimarane precursor followed by rearrangement. It possesses a [3,2,1]-bicyclic ring system with C15-C16 bridge connected to C13, forming the five-membered ring D. Annoglabasin E is an extremely weak basic (essentially neutral) compound (based on its pKa). |
---|
Structure | CC1(CO)CCCC2(C)C3CCC4CC3(CC4C(O)=O)CCC12 InChI=1S/C20H32O3/c1-18(12-21)7-3-8-19(2)15(18)6-9-20-10-13(4-5-16(19)20)14(11-20)17(22)23/h13-16,21H,3-12H2,1-2H3,(H,22,23) |
---|
Synonyms | Value | Source |
---|
ent-19-Hydroxy-16a-kauran-17-Oic acid | HMDB | 5-(Hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylate | Generator |
|
---|
Chemical Formula | C20H32O3 |
---|
Average Molecular Weight | 320.4663 |
---|
Monoisotopic Molecular Weight | 320.23514489 |
---|
IUPAC Name | 5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylic acid |
---|
Traditional Name | 5-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-14-carboxylic acid |
---|
CAS Registry Number | 106454-60-8 |
---|
SMILES | CC1(CO)CCCC2(C)C3CCC4CC3(CC4C(O)=O)CCC12 |
---|
InChI Identifier | InChI=1S/C20H32O3/c1-18(12-21)7-3-8-19(2)15(18)6-9-20-10-13(4-5-16(19)20)14(11-20)17(22)23/h13-16,21H,3-12H2,1-2H3,(H,22,23) |
---|
InChI Key | LKXILSFITASWCO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as kaurane diterpenoids. These are diterpene alkaloids with a structure that is based on the kaurane skeleton. Kaurane is a tetracyclic compound that arises by cyclisation of a pimarane precursor followed by rearrangement. It possesses a [3,2,1]-bicyclic ring system with C15-C16 bridge connected to C13, forming the five-membered ring D. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Diterpenoids |
---|
Direct Parent | Kaurane diterpenoids |
---|
Alternative Parents | Not Available |
---|
Substituents | Not Available |
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 206 - 207 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Annoglabasin E,1TMS,isomer #1 | CC1(CO[Si](C)(C)C)CCCC2(C)C1CCC13CC(CCC12)C(C(=O)O)C3 | 2800.1 | Semi standard non polar | 33892256 | Annoglabasin E,1TMS,isomer #2 | CC1(CO)CCCC2(C)C1CCC13CC(CCC12)C(C(=O)O[Si](C)(C)C)C3 | 2698.6 | Semi standard non polar | 33892256 | Annoglabasin E,2TMS,isomer #1 | CC1(CO[Si](C)(C)C)CCCC2(C)C1CCC13CC(CCC12)C(C(=O)O[Si](C)(C)C)C3 | 2633.9 | Semi standard non polar | 33892256 | Annoglabasin E,1TBDMS,isomer #1 | CC1(CO[Si](C)(C)C(C)(C)C)CCCC2(C)C1CCC13CC(CCC12)C(C(=O)O)C3 | 3075.8 | Semi standard non polar | 33892256 | Annoglabasin E,1TBDMS,isomer #2 | CC1(CO)CCCC2(C)C1CCC13CC(CCC12)C(C(=O)O[Si](C)(C)C(C)(C)C)C3 | 2970.0 | Semi standard non polar | 33892256 | Annoglabasin E,2TBDMS,isomer #1 | CC1(CO[Si](C)(C)C(C)(C)C)CCCC2(C)C1CCC13CC(CCC12)C(C(=O)O[Si](C)(C)C(C)(C)C)C3 | 3168.9 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Annoglabasin E GC-MS (Non-derivatized) - 70eV, Positive | splash10-052g-0192000000-93b26361e9a065bbe7d1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Annoglabasin E GC-MS (2 TMS) - 70eV, Positive | splash10-0092-5038900000-98d86177fb841fc2dd15 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Annoglabasin E GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 10V, Positive-QTOF | splash10-0uk9-0049000000-3b74d2fbd959813ce8ed | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 20V, Positive-QTOF | splash10-0zfr-0194000000-0d5b5b0f2a6b72c6d30d | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 40V, Positive-QTOF | splash10-052f-3791000000-47f362269aa5573d6870 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 10V, Negative-QTOF | splash10-014i-0059000000-cca039b732a5daed4851 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 20V, Negative-QTOF | splash10-069a-0093000000-a27cdb65ad3178df502f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 40V, Negative-QTOF | splash10-052e-1091000000-0f2d47c61e0d8214aa62 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 10V, Negative-QTOF | splash10-014i-0009000000-e9172f49e67d0b8f9e55 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 20V, Negative-QTOF | splash10-014i-0009000000-e9172f49e67d0b8f9e55 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 40V, Negative-QTOF | splash10-00or-0096000000-7609f0470d87a7038f42 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 10V, Positive-QTOF | splash10-00di-0059000000-68d5b9c39e7e216fd560 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 20V, Positive-QTOF | splash10-0l6u-1294000000-099fc65647ca50c44588 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Annoglabasin E 40V, Positive-QTOF | splash10-0540-6981000000-eb5dda93dca0a073b7af | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
General References | - Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
---|